ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceutical Chemicals

South Korea’s SK to acquire Ampac Fine Chemicals

by Michael McCoy
July 14, 2018 | APPEARED IN VOLUME 96, ISSUE 29

The South Korean conglomerate SK Holdings will acquire Ampac Fine Chemicals as part of its plan to become a top-tier pharmaceutical contract development and manufacturing firm. Owned by the private equity firm H.I.G. Capital, Ampac operates plants in California, Texas, and Virginia and is one of the largest U.S. producers of pharmaceutical chemicals. Its Virginia facility was once owned by the drugmaker Boehringer Ingelheim. SK has drug chemical operations in South Korea and last year acquired a Bristol-Myers Squibb plant in Ireland.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment